WE ARE
PHARMACOLOGISTS
The Federation of American Societies for
Experimental Biology is a coalition of life
science societies dedicated to enhancing
the quality of life through research. If you
are a member of the American Society
for Pharmacology and Experimental
Therapeutics you—like more than 65,000
other scientists—are a member of FASEB.
FASEB strives to provide support in
public affairs, distinguished publications,
invaluable meetings and conferences, and
a variety of member services.
FASEB—we are life scientists and we work for you. www.faseb.org
­
=
Online Manuscript
Submission
for three leading journals in pharmacology
jpet.org ‹ molpharm.org ‹ dmd.org
hell is the pl ace where nothing connects — T.S. Eliot
reliable reference linking,
powered by CrossRef
Linking to and from this journal is powered by CrossRef.
CrossRef links millions of articles and chapters, from
thousands of publications, from hundreds of publishers.
So your reference linking works. Permanently. Take a
tour at www.crossref.org. And make sure all your
published work is CrossRef-enabled.
crossref
C R O S S R E F. O R G | T H E C I TAT I O N L I N K I N G B A C K B O N E
4 0 S A L E M S T R E E T, LY N N F I E L D M A 0 1 9 4 0 • 7 8 1 - 2 9 5 - 0 0 7 2
E
C
N
E
I
C
S
O
T
S
S
E
C
C
A
s
e
l
FREE
p
i
c
n
i
r
The 7 P
s for
le
ip
c
in
r
P
C
D
Washington
1
2
ton DC
g
n
i
h
s
a
ment
The W
a commit
is
s
e
l
not-forPrincip
growing)
aintain
ission to m t
m
r
u
o
s
a
y tha
see it
nd visibilit
shers, we
or, trust, a
rofit publi
ation
g
p
ri
rm
r,
fo
e
fo
c
in
tn
f
o
e
o
n
As
depend
le filters
b
in
e
lia
th
re
s
e
a
c
n
ls
and enha
larly journa
arch.
lished scho
ratory rese
o
b
la
d
n
have estab
a
l
a
ic
in
cl
m
fro
venue from
emanating
all of the re e,
t
s
e
v
in
re
e
wid
lishers, w
nce world
profit pub
ort of scie
p
cational
p
u
u
d
s
e
t
,
c
As not-fore
ts
gs, gran
in the dir
tin
e
ls
e
a
ination of
m
rn
u
ic
jo
tif
se
our
free dis m
s, scien
ip
e
h
th
rs
,
g
la
o
in
h
d
n
including sc cacy for research fu
in scientific
dvo
provements
im
d
n
a
,
outreach, a
lic
for the pub
information
and will
publishing.
troduced
in
e
v
a
h
e
access:
ers, w
fit publish owing forms of free ee
ro
p
rfo
to
As n
e foll
t are fr
support th nt articles of interes
continue to
;
n
d importa
atio
3
nd
from 50 (a al/scientific
dic
rs to
profit me
publishe
d
n
a
s
e
ide
societi
ss and w
e
c
c
a
e
e
shed
provide fr
n of publi
o
ti
a
in
m
disse
findings.
research
what
s provide
le
ip
c
in
r
The DC P lled the needed
ca
has been
the
round” in
g
le
d
id
ebate
“m
heated d
ly
g
in
s
a
cate
incre
who advo
e
s
o
th
n
online
betwee
nfettered
u
te
ia
d
e
imm
nd
medical a
s and
access to
h finding
c
r
a
e
s
e
r
nt
scientific
the curre
f
o
s
te
a
c
m. The
advo
ing syste
h
s
li
b
u
p
in
journal
s drafted
a
w
t
n
e
m
s that
docu
cent claim
e
r
to
e
s
respon
actices
shers’ pr
li
b
u
p
e
s
ity to
the
blic’s abil
u
p
e
th
c
r
hinde
d scientifi
e
h
s
li
b
u
access p
.
research
f public
ble to
a. Selecte
the time o
ely availa
online from f our journals is fre tely or
ia
ll text o
er immed
b. The fu
dwide eith
rl
nding on
o
e
w
p
e
e
d
n
,
o
n
o
every
f publicati
o
lishing
s
b
th
u
n
p
o
ess and
within m
in
s
u
b
s
r’
lishe
each pub
e to
ailable fre
nts;
e
m
e
ir
u
q
rnals is av me nations;
re
u
jo
r
u
o
f
-inco
ontent o
many low
c. The c
working in
e online
ts
e
s
fr
ti
n
le
ie
b
c
s
ade availa etween these
m
re
a
s
king b
d. Article
ference lin
through re
exing by
journals;
ble for ind
ila
a
v
a
is
t
nten
at readers
e. Our co
gines so th formation.
n
e
h
rc
a
e
major s
locate in
can easily
worldwide
4
5
6
erm
lop long-t
rk to deve
o
w
to ensure
to
ls
a
e
u
rn
jou
ntin
We will co solutions for online
literature.
on
e scientific
th
f
preservati
o
ty
ili
b
g availa
wers,
the ongoin
, peer-revie d
rs
o
th
u
a
ork with
online an
ntinue to w lopment of robust
e
We will co
v
e
important
d
ir
e
e
for th
cy of th
rs
n
o
ie
it
ic
d
ff
e
e
d
n
ve
a
pro
tools to im
electronic
.
rs
vo
a
e
d
n
e
tion
intellectual
at publica
principle th earchers and
e
th
rt
o
p
p
s
y re
ly su
e solely b
publish
We strong
ot be born
e ability to
n
th
ld
se
u
u
o
h
ca
s
e
fees
to all
tions, b
ble equally
ing institu
ld be availa ir economic
their fund
u
o
sh
ls
a
the
journ
atter what
in scientific
wide, no m
d
rl
o
w
ts
tis
scien
ces.
circumstan
that a free
e believe
w
,
rs
e
h
s
li
ny
profit pub
nce of ma
As not-fore co-existe tinue to work
th
r
fo
s
w
n
o
co
society all
nd we will
igh
models, a
es to set h
publishing r publishing colleagu
se.
ri
rp
te
n
ou
lishing e
b
u
p
y
closely with
rl
la
o
for the sch
standards
7
$
% #&' ( " '" #
#
% ''
'' ( )
"
&
( #
% "#' ( )
# '#' '"
% *
'' " + & '" ,
(
% ' "' #
'
!"##!
Why Publish with ASPET?
Because ASPET gives you these advantages:
♦ Low Page Charges — $35/page for
ASPET members, $70/page for
nonmembers (publishing one paper can
save the $125 membership dues)
♦ Low Color Fees — $200/color figure for
ASPET members, $400/color figure for
nonmembers
The Journal of
PHARMACOLOGY
and Experimental Therapeutics
MOLECULAR
PHARMACOLOGY
DRUG METABOLISM
AND DISPOSITION
♦ Online Manuscript Submission —
submit your manuscript 24/7 —
whenever it suits your schedule; online
peer review reduces review times; track
the progress of your manuscript through
the review process
♦ Publish Online Ahead of Print —
manuscripts are published online shortly
after acceptance — at least two months
prior to print publication
♦ Wide Dissemination — accepted
manuscripts are freely accessible
immediately; fully formatted articles
are freely accessible 12 months after
publication; low-cost pay-per-view
option for nonsubscribers; abstracts and
tables of contents always freely
accessible
Visit www.aspetjournals.org to access each ASPET journal.
ASPET Journals — Widely Read, Highly Respected
Access
1965
Molecular Pharmacolgy
beginning with volume 1, issue 1
The complete
Mol Pharm
archive
is now online!
Molecular Pharmacology starting with volume 1,
issue 1 is now online. All pre-1997 articles are
available as PDF files. Article titles, authors, and
abstracts are fully searchable.
Access to the MolPharm back issues is included
with subscriptions. Nonsubscribers may access
these issues using our pay-per-view system. If
your institution has a print subscription to
MolPharm, you should have online access as well.
Ask your librarian to contact ASPET at
[email protected]. We'll help establish access.
ASPET membership includes online access to all
five ASPET journals. We'll gladly help you activate
your subscription if you haven't done so yet.
Benefit from the full MolPharm archive today!
ASPET continues to make articles from 1997
onward freely available 12 months after publication,
and Fast Forward articles are freely accessible upon
publication.
molpharm.aspetjournals.org
2005